Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was ...

Allosite Therapeutics, a biotechnology company discovering and developing innovative integrin therapies for kidney diseases and other immunologic conditions, today announced that the company will ...

Kidney transplant recipients with active or high risk for antibody-mediated rejection reported transplant benefits but still experienced physical restrictions and psychological concerns, according to ...

MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company’s transdermal GFR ...

Defense Health Agency officials have launched an effort to bring back Medicare-eligible Tricare for Life military patients to ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Viatris has marked its 25-year journey of accompanying Vietnam in the fight against cardiovascular diseases through a series ...

Reverting to pre-COVID telehealth policies could reduce access to care for kidney transplant recipients who live in ...

In a recently published guidance, the ASN aims to help patients with kidney disease navigate the risks inherent to potassium ...

Falling vaccination rates in the US prompted a guidance downgrade at CSL, but was the market's reaction excessive?